Related Experiment Video

Updated: Feb 18, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.6K

The European paediatric legislation: benefits and perspectives

Francesca Rocchi1, Paolo Paolucci, Adriana Ceci

  • 1Ufficio Informazione e Comunicazione - Agenzia Italiana del Farmaco (AIFA), Via del Tritone, 181 - 00187 Roma, Italy. f.rocchi@aifa.gov.it

Italian Journal of Pediatrics
|August 19, 2010
PubMed

Insights

The European Paediatric Regulation aims to improve ethical research and availability of high-quality medicines for children. This initiative seeks to ensure children benefit from authorized treatments without unnecessary trials or delayed adult drug approvals.

Area of Science:

  • Regulatory Science
  • Paediatric Pharmacology
  • Clinical Trials

Background:

  • A significant challenge in paediatric care is the lack of appropriate, approved medicines.
  • Over half of children are prescribed medications off-label or without a license, posing risks.

Purpose of the Study:

  • To analyze the impact and objectives of the European Paediatric Regulation.
  • To ensure the development and availability of high-quality, ethically researched medicines for children aged 0-17.
  • To facilitate access to information on paediatric medicine use while preventing unnecessary trials.

Main Methods:

  • Review of the European Paediatric Regulation (amended January 2007).
  • Analysis of the regulatory changes impacting paediatric medicine development.
  • Examination of potential risks and benefits of the regulation.

Main Results:

  • The Paediatric Regulation is transforming the European regulatory landscape for paediatric medicines.
  • There is a notable increase in clinical trials conducted within the paediatric population.
  • Anticipation and management of potential risks are crucial for the regulation's success.

Conclusions:

  • Medicinal products for children require high-quality ethical research and explicit authorization, mirroring adult drug approvals.
  • The regulation aims to balance the needs of paediatric patients with efficient drug development processes.
  • Careful consideration of risks is necessary to ensure children ultimately benefit from this European initiative.
Abstract

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

52.3K
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.1K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K